MASSIVE HYPERLIPEMIA DURING ESTROGEN THERAPY

被引:80
作者
MOLITCH, ME [1 ]
OILL, P [1 ]
ODELL, WD [1 ]
机构
[1] UNIV CALIF,LOS ANGELES,HARBOR GEN HOSP CAMPUS,SCH MED,DEPT MED,DIV ENDOCRINOL& METAB,BOX 19,TORRANCE,CA 90509
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1974年 / 227卷 / 05期
关键词
D O I
10.1001/jama.227.5.522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:522 / 525
页数:4
相关论文
共 41 条
[31]   THROMBOEMBOLISM AND ORAL CONTRACEPTIVES - AN EPIDEMIOLOGIC CASE-CONTROL STUDY [J].
SARTWELL, PE ;
MASI, AT ;
ARTHES, G ;
GREENE, GR ;
SMITH, HE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 90 (05) :365-&
[32]  
SCHENKER JG, 1971, FERTIL STERIL, V22, P604
[33]   HYPERTENSION AND ORAL CONTRACEPTION [J].
SMITH, RW .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1972, 113 (04) :482-&
[34]  
STOKES T, 1971, LANCET, V2, P677
[35]   INVESTIGATION OF RELATION BETWEEN USE OF ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE [J].
VESSEY, MP ;
DOLL, R .
BMJ-BRITISH MEDICAL JOURNAL, 1968, 2 (5599) :199-+
[36]   CAN WE PREVENT HEART DISEASE [J].
WERKO, L .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (02) :278-+
[37]  
WYNN V, 1969, LANCET, V2, P756
[38]  
WYNN V, 1969, LANCET, V2, P761
[39]   SOME EFFECTS OF ORAL CONTRACEPTIVES ON SERUM-LIPID AND LIPOPROTEIN LEVELS [J].
WYNN, V ;
DOAR, JWH ;
MILLS, GL .
LANCET, 1966, 2 (7466) :720-&
[40]  
ZORILLA E, 1968, J CLIN ENDOCR METAB, V28, P1793